Formed in 2019 with a core focus of moving patient care forward through the development of commercially viable technologies. These technologies must aim to address serious unmet medical needs for patients.
Hibiscus has the capabilities to build and develop patient-focused companies by bringing all the necessary resourcing in-house. We leverage a differentiated venture studio model to build Studio Companies in combination with Hibiscus Capital Management, our venture capital investment arm.
The Hibiscus team has decades of investment and operational experience taking scientific discoveries from the lab bench to patients’ bedsides.